HBV Mutation Detail Information

> L180M Search Result


Mutation Information
Mutation Site L180M
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.M204I+rt.L180M;rt.M204V+rt.L180M
Relevant Drug lamivudine (LAM)
Country Malawi
Literature Information
PubMed PMID 22930502
Disease HBV-HIV coinfection
Published Year 2012
Journal Journal of medical virology
Title Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
Author Galluzzo C,Liotta G,Andreotti M,Luhanga R,Jere H,Mancinelli S,Maulidi M,Sagno JB,Pirillo M,Erba F,Amici R,Ceffa S,Marazzi MC,Vella S,Palombi L,Giuliano M
Evidence Resistance mutations (M204I in five cases and L180M + M204I/V in one case) were present in 6 (28.6%) patients.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation